Mylan posts 17 pct rise in revenue
May 03, 2016 at 03:06 AM EDT
May 3 (Reuters) - Drugmaker Mylan NV posted an 17 percent rise in quarterly revenue, helped by higher sales of generic drugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.